Product Information
FLUTICASONE PROP 0.05% CREAM is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.3683 per GM under NDC 00168033215. Its NADAC has been published 610 times since Nov 28, 2013.
FDA first approved this application on May 14, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
NDC
00168033215
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
7/23/2025
Active Ingredients
FLUTICASONE PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076451FDA Approved
5/14/2004
TE Code
AB
On Market Since
5/14/2004
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE PROP 0.05% CREAM has been published 610 times since Nov 28, 2013, and over the history we have for it it has declined 27.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3683 per GM |
|---|---|
| All-time high | $0.5313 (Feb 12, 2014) |
| All-time low | $0.2433 (Apr 17, 2024) |
| Median price | $0.3835 |
| Average price | $0.3878 |
| Largest weekly change | +42.8% (Aug 17, 2016) |
| Weeks tracked | 610 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-8.3%
5Y
+10.9%
All
-27.2%
Last surveyed Jul 30, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE PROP 0.05% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE PROP 0.05% CREAM, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.3683 per GM (NDC 00168033215), effective Jul 30, 2025.
How has the price of FLUTICASONE PROP 0.05% CREAM changed over time?
Over the history we have for it, the NADAC for FLUTICASONE PROP 0.05% CREAM has declined 27.2%. It has been tracked across 610 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUTICASONE PROP 0.05% CREAM?
Since Nov 28, 2013, the NADAC for FLUTICASONE PROP 0.05% CREAM has ranged from a low of $0.2433 (Apr 17, 2024) to a high of $0.5313 (Feb 12, 2014), with a median of $0.3835 per GM.
Are there cheaper alternatives to FLUTICASONE PROP 0.05% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE PROP 0.05% CREAM, is $0.2367 per GM — about 36% below FLUTICASONE PROP 0.05% CREAM.
Who manufactures FLUTICASONE PROP 0.05% CREAM?
FLUTICASONE PROP 0.05% CREAM (NDC 00168033215) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.